Ibritumomab Intravenous and QNASL

• Generic Name: ibritumomab
• Dosage Forms: n.a.
• Other Brand Names: Y-90 Zevalin, In-111 Zevalin

Ibritumomab injection is a monoclonal antibody. It is used together with another monoclonal antibody (rituximab) and one radioactive medication (Y-90). Ibritumomab is used to treat a type of cancer called non-Hodgkin's lymphoma (NHL) in patients who have never received any treatment and for those who have received other cancer medicines.

Ibritumomab is to be administered only by or under the immediate supervision of your doctor.

• Generic Name: beclomethasone nasal
• Dosage Forms: aerosol, metered
• Other Brand Names: Beconase AQ, QNASL, QNASL, Beconase, Vancenase, Vancenase AQ, Vancenase AQ DS

QNASL contains beclomethasone, a corticosteroid. It prevents the release of substances in the body that cause inflammation.

QNASL Nasal Aerosol (80 mcg) is a prescription medicine that treats seasonal nasal and year-round nasal allergy symptoms, such as congestion, sneezing, and runny nose in adults and children 12 years of age and older.

QNASL Nasal Aerosol (40 mcg) is used for the treatment of nasal allergy symptoms in children 4-11 years of age.